内在的抗炎纳米药物用于增强疼痛管理
Bin Qiao1, Jiaqian Yao1, Yu'ang Fan2
1Department of Medical Ultrasonics, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Frontiers in bioengineering and biotechnology
|December 31, 2024
概括
这项研究引入了一种新的纳米药物,将局部麻醉剂与抗炎性质相结合,以增强术后疼痛缓解. 开发的纳米平台在动物模型中表现出长时间的止痛作用和减少炎症.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于阿片类药物的副作用和当前止痛药的局限性,有效的术后疼痛管理具有挑战性.
- 炎症显著加剧疼痛,需要结合止痛和抗炎作用的疗法.
研究的目的:
- 开发一种内在的抗炎纳米药物,以改善疼痛管理.
- 为了将受控麻醉释放与固有的抗炎活性相结合.
主要方法:
- 状半孔纳米颗粒 (MSN) 装满了levobupivacaine.
- 这些MSN被涂上了源自人参酸Rg3的基于Rg3的脂质体,从而创建了LMSN-bupi纳米平台.
- 动物模型被用来评估镇痛效应和炎症反应.
主要成果:
- 该LMSN-bupi纳米平台证明了Levobupivacaine的持续和受控释放.
- 通过抑制巨细胞激活,Rg3-脂质体涂层提供了内在的抗炎作用.
- 与对照纳米粒子相比,观察到明显延长的止痛效应和减弱的炎症反应.
结论:
- 内在的抗炎纳米药物显示了增强术后疼痛管理的潜力.
- 这一策略为克服现有疼痛治疗方法的局限性提供了一个有希望的方法.
- 开发的纳米医学可以改善患者在术后护理的结果.
相关概念视频
Analgesia and Pain Management
390
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
390
Nociception
27.5K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.5K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
163
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
163
Drug Delivery: Miscellaneous Routes
269
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
269
Opioid Analgesics: Morphine and Other Natural Cogeners
132
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
132
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
96
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
96


